Euglena Co., Ltd. (FRA:8EG)

Germany flag Germany · Delayed Price · Currency is EUR
2.020
+0.050 (2.54%)
At close: Mar 27, 2026
Market Cap286.13M -32.4%
Revenue (ttm)273.62M +5.8%
Net Income-4.37M
EPS-0.03
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividend0.01 (0.54%)
Ex-Dividend DateDec 29, 2025
Volumen/a
Average Volume23
Open2.020
Previous Close1.970
Day's Range2.020 - 2.020
52-Week Range1.930 - 3.280
Betan/a
RSI48.36
Earnings DateMay 14, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business. Further, it produces, processes, and sells euglena, chlorella, watermelon, and midori koji; and manufactures and sells organic fertilizer. Additionally, the company provides genome analysis services. Euglena Co., Ltd. was incorpor... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 897
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8EG

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.

Financial numbers in JPY Financial Statements